BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27996321)

  • 1. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
    Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
    Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?
    Fabris C; Patek SD; Breton MD
    J Diabetes Sci Technol; 2015 Aug; 10(1):50-9. PubMed ID: 26275643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
    Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
    Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
    [No Abstract]   [Full Text] [Related]  

  • 12. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.
    Gómez AM; Muñoz OM; Marin A; Fonseca MC; Rondon M; Robledo Gómez MA; Sanko A; Lujan D; García-Jaramillo M; León Vargas FM
    J Diabetes Sci Technol; 2018 Sep; 12(5):1007-1015. PubMed ID: 29451006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
    Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
    Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.
    Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes.
    Henao-Carrillo DC; Muñoz OM; Gómez AM; Rondón M; Colón C; Chica L; Rubio C; León-Vargas F; Calvachi MA; Perea AM
    J Clin Transl Endocrinol; 2018 Jun; 12():8-12. PubMed ID: 29892561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Data Loss of Glycemic Variability Measurements in Long-Term Continuous Glucose Monitoring.
    Kucharski P; Pagacz K; Szadkowska A; Młynarski W; Romanowski A; Fendler W
    Diabetes Technol Ther; 2018 Dec; 20(12):833-842. PubMed ID: 30403500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.